Hemostasis and Tissue Sealing Agents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Published Feb 21, 2023

Length 145 Pages

SKU # IMRC17808561

Description

Hemostasis and Tissue Sealing Agents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

The global hemostasis and tissue sealing agents market size reached US$ 6.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.6 Billion by 2028, exhibiting a growth rate (CAGR) of 7.1% during 2023-2028.

Hemostasis is a normal physiological response of the body, which regulates blood fluidity by stopping blood loss from the damaged blood vessel through hemostats. On the other hand, tissue sealing prevents perioperative hemorrhage and controls blood loss from damaged tissues through tissue sealing agents. Hemostats and tissue sealing agents are both used to compress blood vessels and avoid hemorrhage, blood flow, and other fluid discharge. They include thrombin sealant, fibrin glue, bovine serum or albumin, and gelatin matrix. They ensure blood fluidity and blood vessel integrity and help reduce wound healing and operative time, minimize the recovery time and hospital stay and provide better management of anticoagulated patients. They are used to disperse raw surface bleeding, bone bleeding, oozing venous bleeds, and needle-opening bleeding. At present, they are easily available in the market with varying compositions, mechanisms of action, cost, application, and adherence.

Hemostasis and Tissue Sealing Agents Market Trends:
The increasing global geriatric population and chronic medical conditions represent one of the key factors positively influencing the market. The rising participation of individuals in physical activities, along with the increasing occurrence of injuries caused during workouts and sports and physical activities, is catalyzing the demand for hemostasis and tissue sealing agents across the globe. In addition, rising cases of road accidents and gastrointestinal, pulmonary, and cardiovascular surgeries are increasing the demand for hemostats and tissue sealing. Apart from this, shifting consumer preference toward minimally invasive surgeries (MIS) for minimal incision and blood loss and faster recovery time is offering lucrative growth opportunities to manufacturers. Furthermore, leading market players are focusing on the development of multi-usage and ready-to-use products, which is expected to propel market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemostasis and tissue sealing agents market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, material type, application and end user.

Breakup by Product Type:

Topical Hemostats
Adhesive and Tissue Sealant

Breakup by Material Type:

Collagen-based
Oxidized Regenerated Cellulose (ORC) based
Gelatin-based
Polysaccharide-based
Others

Breakup by Application:

General Surgery
Minimally Invasive Surgery
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advance Medical Solution Group Plc., Artivion Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson & Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Smith & Nephew plc and Terumo Corporation.

Key Questions Answered in This Report

1. What was the size of the global hemostasis and tissue sealing agents market in 2022?
2. What is the expected growth rate of the global hemostasis and tissue sealing agents market during 2023-2028?
3. What are the key factors driving the global hemostasis and tissue sealing agents market?
4. What has been the impact of COVID-19 on the global hemostasis and tissue sealing agents market?
5. What is the breakup of the global hemostasis and tissue sealing agents market based on the product type?
6. What is the breakup of the global hemostasis and tissue sealing agents market based on the application?
7. What are the key regions in the global hemostasis and tissue sealing agents market?
8. Who are the key players/companies in the global hemostasis and tissue sealing agents market?

1 Preface
2 Scope and Methodology: 2.1 Objectives of the Study; 2.2 Stakeholders; 2.3 Data Sources; 2.3.1 Primary Sources; 2.3.2 Secondary Sources; 2.4 Market Estimation; 2.4.1 Bottom-Up Approach; 2.4.2 Top-Down Approach; 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction: 4.1 Overview; 4.2 Key Industry Trends
5 Global Hemostasis and Tissue Sealing Agents Market: 5.1 Market Overview; 5.2 Market Performance; 5.3 Impact of COVID-19; 5.4 Market Forecast
6 Market Breakup by Product Type: 6.1 Topical Hemostats; 6.1.1 Market Trends; 6.1.2 Market Forecast; 6.2 Adhesive and Tissue Sealant; 6.2.1 Market Trends; 6.2.2 Market Forecast
7 Market Breakup by Material Type: 7.1 Collagen-based; 7.1.1 Market Trends; 7.1.2 Market Forecast; 7.2 Oxidized Regenerated Cellulose (ORC) based; 7.2.1 Market Trends; 7.2.2 Market Forecast; 7.3 Gelatin-based; 7.3.1 Market Trends; 7.3.2 Market Forecast; 7.4 Polysaccharide-based; 7.4.1 Market Trends; 7.4.2 Market Forecast; 7.5 Others; 7.5.1 Market Trends; 7.5.2 Market Forecast
8 Market Breakup by Application: 8.1 General Surgery; 8.1.1 Market Trends; 8.1.2 Market Forecast; 8.2 Minimally Invasive Surgery; 8.2.1 Market Trends; 8.2.2 Market Forecast; 8.3 Others; 8.3.1 Market Trends; 8.3.2 Market Forecast
9 Market Breakup by End User: 9.1 Hospitals; 9.1.1 Market Trends; 9.1.2 Market Forecast; 9.2 Ambulatory Surgical Centers; 9.2.1 Market Trends; 9.2.2 Market Forecast; 9.3 Home Care Settings; 9.3.1 Market Trends; 9.3.2 Market Forecast; 9.4 Others; 9.4.1 Market Trends; 9.4.2 Market Forecast
10 Market Breakup by Region: 10.1 North America; 10.1.1 United States; 10.1.1.1 Market Trends; 10.1.1.2 Market Forecast; 10.1.2 Canada; 10.1.2.1 Market Trends; 10.1.2.2 Market Forecast; 10.2 Asia-Pacific; 10.2.1 China; 10.2.1.1 Market Trends; 10.2.1.2 Market Forecast; 10.2.2 Japan; 10.2.2.1 Market Trends; 10.2.2.2 Market Forecast; 10.2.3 India; 10.2.3.1 Market Trends; 10.2.3.2 Market Forecast; 10.2.4 South Korea; 10.2.4.1 Market Trends; 10.2.4.2 Market Forecast; 10.2.5 Australia; 10.2.5.1 Market Trends; 10.2.5.2 Market Forecast; 10.2.6 Indonesia; 10.2.6.1 Market Trends; 10.2.6.2 Market Forecast; 10.2.7 Others; 10.2.7.1 Market Trends; 10.2.7.2 Market Forecast; 10.3 Europe; 10.3.1 Germany; 10.3.1.1 Market Trends; 10.3.1.2 Market Forecast; 10.3.2 France; 10.3.2.1 Market Trends; 10.3.2.2 Market Forecast; 10.3.3 United Kingdom; 10.3.3.1 Market Trends; 10.3.3.2 Market Forecast; 10.3.4 Italy; 10.3.4.1 Market Trends; 10.3.4.2 Market Forecast; 10.3.5 Spain; 10.3.5.1 Market Trends; 10.3.5.2 Market Forecast; 10.3.6 Russia; 10.3.6.1 Market Trends; 10.3.6.2 Market Forecast; 10.3.7 Others; 10.3.7.1 Market Trends; 10.3.7.2 Market Forecast; 10.4 Latin America; 10.4.1 Brazil; 10.4.1.1 Market Trends; 10.4.1.2 Market Forecast; 10.4.2 Mexico; 10.4.2.1 Market Trends; 10.4.2.2 Market Forecast; 10.4.3 Others; 10.4.3.1 Market Trends; 10.4.3.2 Market Forecast; 10.5 Middle East and Africa; 10.5.1 Market Trends; 10.5.2 Market Breakup by Country; 10.5.3 Market Forecast
11 SWOT Analysis: 11.1 Overview; 11.2 Strengths; 11.3 Weaknesses; 11.4 Opportunities; 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis: 13.1 Overview; 13.2 Bargaining Power of Buyers; 13.3 Bargaining Power of Suppliers; 13.4 Degree of Competition; 13.5 Threat of New Entrants; 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape: 15.1 Market Structure; 15.2 Key Players; 15.3 Profiles of Key Players; 15.3.1 Advance Medical Solution Group Plc.; 15.3.1.1 Company Overview; 15.3.1.2 Product Portfolio; 15.3.1.3 Financials; 15.3.1.4 SWOT Analysis; 15.3.2 Artivion Inc.; 15.3.2.1 Company Overview; 15.3.2.2 Product Portfolio; 15.3.2.3 Financials; 15.3.2.4 SWOT Analysis; 15.3.3 B. Braun Melsungen AG; 15.3.3.1 Company Overview; 15.3.3.2 Product Portfolio; 15.3.4 Baxter International Inc.; 15.3.4.1 Company Overview; 15.3.4.2 Product Portfolio; 15.3.4.3 Financials; 15.3.4.4 SWOT Analysis; 15.3.5 Becton, Dickinson & Company; 15.3.5.1 Company Overview; 15.3.5.2 Product Portfolio; 15.3.5.3 Financials; 15.3.5.4 SWOT Analysis; 15.3.6 Integra LifeSciences Corporation; 15.3.6.1 Company Overview; 15.3.6.2 Product Portfolio; 15.3.6.3 Financials; 15.3.6.4 SWOT Analysis; 15.3.7 Johnson & Johnson; 15.3.7.1 Company Overview; 15.3.7.2 Product Portfolio; 15.3.7.3 Financials; 15.3.7.4 SWOT Analysis; 15.3.8 Medtronic plc; 15.3.8.1 Company Overview; 15.3.8.2 Product Portfolio; 15.3.8.3 Financials; 15.3.8.4 SWOT Analysis; 15.3.9 Pfizer Inc.; 15.3.9.1 Company Overview; 15.3.9.2 Product Portfolio; 15.3.9.3 Financials; 15.3.9.4 SWOT Analysis; 15.3.10 Smith & Nephew plc; 15.3.10.1 Company Overview; 15.3.10.2 Product Portfolio; 15.3.10.3 Financials; 15.3.10.4 SWOT Analysis; 15.3.11 Terumo Corporation; 15.3.11.1 Company Overview; 15.3.11.2 Product Portfolio; 15.3.11.3 Financials; 15.3.11.4 SWOT Analysis

Pricing

Currency Rates

Single User Email from Publisher $2,999
Five User License Fulfilled by Publisher $3,999
Global Site License Email from Publisher $4,999

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now